Today: 11 June 2026
Browse Category

ASX:ALX 6 January 2026 - 27 April 2026

Australia Stock Market Today: ASX 200 Falls For Fifth Day As Oil Shock Hits Banks, Origin

Australia Stock Market Today: ASX 200 Falls For Fifth Day As Oil Shock Hits Banks, Origin

Australia’s S&P/ASX 200 fell 20.1 points, or 0.23%, to 8,766.40 on Monday, marking a fifth straight loss as energy, utilities, and banks declined. Origin Energy dropped 5.25% after weaker LNG revenue, while Atlas Arteria jumped on a takeover offer from IFM. Nine of 11 sectors fell. The Australian dollar traded near 71.61 U.S. cents late in the session.
27 April 2026
····
Transurban Group Ltd stock slides after ASX close as inflation test nears — what to know

Transurban Group Ltd stock slides after ASX close as inflation test nears — what to know

Transurban shares fell 2.4% to A$13.70 Tuesday as traders cut exposure to rate-sensitive stocks ahead of Australia’s November inflation data. The company disclosed it issued 50,561 unquoted performance awards under its long-term incentive plan. The S&P/ASX 200 closed down 0.52%. Investors are watching Wednesday’s CPI release and Transurban’s February results.
6 January 2026
····

Stock Market Today

  • Redwire Stock Rises on $500 Million At-The-Market Share Sale Plan
    June 11, 2026, 10:42 AM EDT. Redwire (RDW) shares climbed Thursday following the announcement of a $500 million at-the-market (ATM) equity program, allowing the company to gradually sell new shares at market prices. The move aims to boost cash for working capital, debt refinancing, acquisitions, and R&D, but introduces dilution risk as existing shareholders' stakes may decrease. Shares opened at $14.88, peaked at $16.26, and last traded at $16.11, up $1.24 from the prior close, with nearly 9.7 million shares changing hands. The new shares could increase the total outstanding from 238.8 million to around 265.8 million, depending on sale prices. Market reaction reflects investor uncertainty about dilution balanced against Redwire's growth funding needs.

Latest articles

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
Redwire Stock Bounces as $500 Million Share Sale Draws Focus

Redwire Stock Bounces as $500 Million Share Sale Draws Focus

11 June 2026
Redwire stock jumped $1.24 to $16.11 Thursday after unveiling a $500 million at-the-market share sale, raising investor concerns about dilution versus growth funding; the new program could increase shares outstanding by about 11%, with the company’s 2026 revenue forecast and backlog now under scrutiny to justify the added supply.
Coupang Rises as $410 Million Korea Data Fine Finally Lands

Coupang Rises as $410 Million Korea Data Fine Finally Lands

11 June 2026
Coupang shares jumped 5.6% after South Korea imposed a record $410 million privacy fine for a 2025 data breach, as investors welcomed clarity on regulatory risk despite the penalty hitting Q2 operating expenses; the company plans to appeal, but ongoing customer trust and margin pressures remain key risks.
Go toTop